Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van Wezel

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Molecular Diagnostics : JMD|December 30, 2014
Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissueStijn Crobach, Dina Ruano, Ronald van Eijk, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 25, 2015
Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cellsCaroline van Haaften, Arnoud Boot, Willem E Corver, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2005
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancerMarjo van Puijenbroek, Jan Willem F Dierssen, Patrick Stanssens, et al.
Genome Research|February 3, 2007
High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArraysJan Oosting, Esther H Lips, Ronald van Eijk, et al.
Endocrine-Related Cancer|October 23, 2024
Chromosomal alteration patterns in PitNETs: massive losses in aggressive tumorsMaaia Margo Jentus, Leontine Bakker, Marco Verstegen, et al.
The Journal of Pathology|June 7, 2016
Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cellsArnoud Boot, Jan Oosting, Noel Fcc de Miranda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinomaJanneke E Witteveen, Neveen A T Hamdy, Olaf M Dekkers, et al.
BMC Genomics|February 22, 2007
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancerJudith N Kloth, Jan Oosting, Tom van Wezel, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2018
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation SequencingSuk Wai Lam, Anne-Marie Cleton-Jansen, Arjen H G Cleven, et al.
Cancers|September 28, 2023
Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E TargetingRiet Hilhorst, Adrienne van den Berg, Piet Boender, et al.
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Molecular Diagnostics : JMD|December 30, 2014
Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissueStijn Crobach, Dina Ruano, Ronald van Eijk, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 25, 2015
Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cellsCaroline van Haaften, Arnoud Boot, Willem E Corver, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2005
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancerMarjo van Puijenbroek, Jan Willem F Dierssen, Patrick Stanssens, et al.
Genome Research|February 3, 2007
High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArraysJan Oosting, Esther H Lips, Ronald van Eijk, et al.
Endocrine-Related Cancer|October 23, 2024
Chromosomal alteration patterns in PitNETs: massive losses in aggressive tumorsMaaia Margo Jentus, Leontine Bakker, Marco Verstegen, et al.
The Journal of Pathology|June 7, 2016
Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cellsArnoud Boot, Jan Oosting, Noel Fcc de Miranda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2011
Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinomaJanneke E Witteveen, Neveen A T Hamdy, Olaf M Dekkers, et al.
BMC Genomics|February 22, 2007
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancerJudith N Kloth, Jan Oosting, Tom van Wezel, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2018
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation SequencingSuk Wai Lam, Anne-Marie Cleton-Jansen, Arjen H G Cleven, et al.
Cancers|September 28, 2023
Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E TargetingRiet Hilhorst, Adrienne van den Berg, Piet Boender, et al.
Pageof 22